Navigation Links
Salmon genome in final phases of completion

The International Cooperation to Sequence the Atlantic Salmon Genome (ICSASG, the "Cooperation") has awarded the Phase II contract for next-generation sequencing and analysis of the Atlantic salmon genome to the J. Craig Venter Institute (JCVI) in Rockville, Maryland. The JCVI will be sequencing the salmon genome using next-generation technologies, including assembly to integrate Sanger and next-generation sequence, and comparative genomics. This effort is expected to generate a high-quality resource for those responsible for the management of wild salmon stocks and the salmon aquaculture industry, as well as providing a reference genome for work with other salmonids.

The Cooperation was formed in 2009 as a partnership between the Research Council of Norway, the Norwegian Fishery and Aquaculture Industry Research Fund, Genome British Columbia, and the Chilean Economic Development Agency (CORFO) and its Innovation Agency InnovaChile. The group brings together expert biologists who have studied salmonids with commercial and government agencies interested in funding further study. Salmonids play a key commercial and environmental role; while some salmon genetic information is known, many fundamental questions remain.

"A fully annotated salmon genome will provide important information about the impact of cultured fish escapees on wild populations, about preservation of populations that are at risk, about strategies for fighting pathogens, and about environmental sustainability issues," says ICSASG chair Dr. Steinar Bergseth at the Research Council of Norway. "A fully assembled reference sequence available for researchers worldwide will have a major impact on research into salmon and other salmonids, such as rainbow trout."

"This is a good example showing that science allows nations and institutions to cooperate on a field where they usually are competitors" says CEO Gonzalo J. Herrera of CONICYT.

"The salmon genome is large and contains repetitive sequences which make it a more difficult genome sequence to assemble. Working with ICSASG, we will complement the Phase I data with next-generation sequence data to provide the most complete salmon genome possible," says Dr. Jason Miller PhD, an associate professor at JCVI.

Worldwide, commercial salmon production exceeds one billion pounds annually, with about 70% coming from aquaculture salmon farms. In addition to being an important economic resource, salmon and other salmonidae species such as trout are considered "sentinel species" for monitoring water quality, and are important markers for ecotoxicology studies.

"This project is a novel approach to addressing issues that are of economic and social importance to aquaculture, conservation, and the environment," says Dr. Alan Winter, President & CEO of Genome BC.


Contact: Jenny Boon
Genome BC

Related biology news :

1. Environmental conditions and predators affect Atlantic salmon survival in the Gulf of Maine
2. Salmon and other fish predators rely on no guts, no glory survival tactic
3. Warming streams could be the end for salmon
4. The same number of fishermen, but less salmon in Spanish rivers
5. Newfound hijacked proteins linked to salmonella virulence
6. E. coli, salmonella may lurk in unwashable places in produce
7. Parasite loads an underlying cause of salmon mortality, linked to land use changes
8. Salmonella stays deadly with a beta version of cell behavior
9. Scientist urges government ruling on genetically engineered salmon
10. Models show Coho salmon at risk in US urbanizing watersheds
11. New target found for nitric oxides attack on salmonella bacteria
Post Your Comments:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology: